John Armitage’s Nutrien NTR Stock Holding History

John Armitage’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,472,993	Closed	-$163M	–	29
2018 Q4	$163M	Sell	3,472,993 -950,307	-21%	-$49.6M	1.36%	21
2018 Q3	$255M	Buy	4,423,300 +1,762,773	+66%	+$97.6M	1.89%	21
2018 Q2	$145M	Buy	+2,660,527	New	+$132M	1.11%	28

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

John Armitage's NTR Position: Q1 2019 in Review

John Armitage sold out of Nutrien (NTR) in Q1 2019, closing a stake of 3,472,993 shares — an estimated $163M sold.

John Armitage first reported a position in NTR in Q2 2018 and held it in 3 quarters. The position peaked at $255M in Q3 2018. 578 funds tracked by Wall St. Rank hold NTR as of Q1 2019.

John Armitage reported no remaining Nutrien position as of Q1 2019 after selling out during the quarter.
John Armitage sold 3,472,993 Nutrien shares in Q1 2019, an estimated $163M.
John Armitage first reported a position in Nutrien in Q2 2018 and held it in 3 quarters.
John Armitage's Nutrien position peaked at $255M in Q3 2018.
578 funds tracked by Wall St. Rank held Nutrien as of Q1 2019.

Based on Egerton Capital (UK)'s 13F filing for Q1 2019, filed 9 May 2019.